Yasin Norafiza Mohd, Hassan Syahzuwan, Aziz Nur Aisyah, Abdul Hamid Faidatul Syazlin, Esa Ezalia, Zulkefli Ezzanie Suffya, Ghazali Rohana, Tajuddin Syirah Nazirah, Darawi Mohd Nazif, Yusoff Yuslina Mat, Harteveld Cornelis L
Haematology Unit, Cancer Research Centre (CaRC), Institute for Medical Research (IMR), National Institute for Health (NIH), Shah Alam 40170, Selangor, Malaysia.
Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands.
Diagnostics (Basel). 2025 May 20;15(10):1284. doi: 10.3390/diagnostics15101284.
Poly A (AATAAA > AATA--) [HBA2:c.*93_*94delAA] is a rare α-variant reported in our population. It is caused by 2 bp deletion (--AA) in the α2 poly A sequence, leading to a significant α-thalassaemia phenotype. : This study describes the haematological parameters, phenotype, and genotype characteristics of AATA(--AA) in the Malaysian population. : The study was carried out on 17 177 cases referred to the Institute for Medical Research, Malaysia, for further diagnosis of α-thalassaemia in a five-year period. Alpha-Gap and ARMS-PCR were performed to detect common α-thalassaemia, followed by and genes sequencing and multiplex ligation-dependent probe amplification (MLPA). Haematological parameters among various groups with the AATA(--AA) allele were presented in this study. : Thirty-two patients with AATA(--AA) displaying an α-thalassaemia-like phenotype were analysed. They comprised 22 (68.75%) AATA(--AA) carriers, 2 (6.25%) compounds with 3.7 deletion, 2 (6.25%) compounds with --SEA deletion, 1 (3.12%) AATA(--AA) homozygote, and 3 (9.37%) compounds of Hb Adana, Hb CS, and Hb Pakse with co-inheritance Hb E, respectively. Most of the patients with AATA(--AA) compounds with the α-variant exhibited a significant phenotype between moderate to severe thalassaemia, especially cases with compound αα/αα. : AATA(--AA) is a significant pathogenic variant that should be diagnosed to prevent significant thalassaemia phenotype or transfusion-dependent thalassaemia.
聚腺苷酸(AATAAA > AATA--)[HBA2:c.*93_*94delAA]是在我们人群中报道的一种罕见的α变异体。它由α2聚腺苷酸序列中的2个碱基对缺失(--AA)引起,导致明显的α地中海贫血表型。:本研究描述了马来西亚人群中AATA(--AA)的血液学参数、表型和基因型特征。:该研究对在五年期间转诊至马来西亚医学研究所进行α地中海贫血进一步诊断的17177例病例进行。进行了α-间隙和ARMS-PCR检测常见的α地中海贫血,随后进行了 和 基因测序以及多重连接依赖探针扩增(MLPA)。本研究展示了具有AATA(--AA)等位基因的不同组之间的血液学参数。:对32例表现出α地中海贫血样表型的AATA(--AA)患者进行了分析。其中包括22例(68.75%)AATA(--AA)携带者、2例(6.25%)与3.7缺失的复合杂合子、2例(6.25%)与--SEA缺失的复合杂合子、1例(3.12%)AATA(--AA)纯合子以及3例(9.37%)分别与Hb Adana、Hb CS和Hb Pakse复合且共同遗传Hb E的患者。大多数携带α变异体的AATA(--AA)复合杂合子患者表现出中度至重度地中海贫血之间的明显表型,尤其是αα/αα复合杂合子病例。:AATA(--AA)是一种重要的致病变异体,应进行诊断以预防明显的地中海贫血表型或输血依赖型地中海贫血。